The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

130 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters.EBI
National Institute of Diabetes and Digestive and Kidney Diseases
Norbenzomorphan Scaffold: Chemical Tool for Modulating Sigma Receptor-Subtype Selectivity.EBI
The University of Texas At Austin
2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as AEBI
National Institute of Diabetes and Digestive and Kidney Disease
Conformationally Restricted σEBI
Westf£Lische Wilhelms-Universit£T M£Nster
Indazole as a Phenol Bioisostere: Structure-Affinity Relationships of GluN2B-Selective NMDA Receptor Antagonists.EBI
University Munster
Dual EBI
Ghent University
Dual Piperidine-Based Histamine HEBI
Jagiellonian University Medical College
2,6-diazaspiro[3.4]octan-7-one derivatives as potent sigma-1 receptor antagonists that enhanced the antinociceptive effect of morphine and rescued morphine tolerance.EBI
Xuzhou Medical University
Targeting σEBI
The University of Texas At Austin
2-Phenylcyclopropylmethylamine (PCPMA) as a privileged scaffold for central nervous system drug design.EBI
Shanghaitech University
Alicyclic Ring Size Variation of 4-Phenyl-2-naphthoic Acid Derivatives as P2YEBI
National Institute of Diabetes and Digestive and Kidney Diseases
Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents.EBI
University of Pavia
Discovery and computational studies of piperidine/piperazine-based compounds endowed with sigma receptor affinity.EBI
University of Messina
Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity.EBI
Universit£
What We Have Gained from Ibogaine: α3β4 Nicotinic Acetylcholine Receptor Inhibitors as Treatments for Substance Use Disorders.EBI
University of Illinois At Chicago
Pharmacology and Therapeutic Potential of Benzothiazole Analogues for Cocaine Use Disorder.EBI
High Point University
Discovery of WLB-89462, a New Drug-like and Highly Selective σEBI
Welab Barcelona
Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer.EBI
University of Michigan
Benzomorphan skeleton, a versatile scaffold for different targets: A comprehensive review.EBI
University of Catania
Development of Fluorescent 4-[4-(3EBI
University of Bari Aldo Moro
From dopamine 4 to sigma 1: Synthesis, SAR and biological characterization of a piperidine scaffold of σ1 modulators.EBI
University of Nebraska Medical Center
Structure-activity relationships of mixed σEBI
University of Catania
Synthesis and pharmacological characterization of multiply substituted 2H-chromene derivatives as P2YEBI
National Institute of Diabetes and Digestive and Kidney Diseases
Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward Metastasis.EBI
University of Kansas
Discovery and Characterization of the First Nonpeptide Antagonists for the Relaxin-3/RXFP3 System.EBI
Research Triangle Institute
Preparation of novel analogs of 2-arylpiperidines and evaluation of their sigma receptor binding affinities.EBI
University of Texas At Austin
Synthesis of tropane-based σEBI
Westf£Lische Wilhelms-Universit£T M£Nster
Synthesis of 8-aminomorphans with high KOR affinity.EBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
The Alkaloids from EBI
University of Copenhagen
Discovery of Highly Potent Serotonin 5-HTEBI
Northwestern University
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation.EBI
University of Catania
Synthesis and biological evaluation of conformationally restricted GluN2B ligands derived from eliprodil.EBI
Westf£Lische Wilhelms-Universit£T M£Nster
Discovery of Potent Cholinesterase Inhibition-Based Multi-Target-Directed Lead Compounds for Synaptoprotection in Alzheimer's Disease.EBI
Yeditepe University
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands.EBI
University of Trieste
Research progress in biological activities of isochroman derivatives.EBI
Shaanxi University of Chinese Medicine
Benzylaminofentanyl derivates: Discovery of bifunctional μ opioid and σEBI
Jiangsu Ocean University
Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors.EBI
Beijing Normal University
Development of tumor-targeting aza-vesamicol derivatives with high affinity for sigma receptors for cancer theranostics.EBI
Kanazawa University
Structure-Activity Studies of 1EBI
National Institute of Diabetes and Digestive and Kidney Diseases
Tricyclic Triazoles as σEBI
Esteve Pharmaceuticals
Spirocyclic Scaffolds in Medicinal Chemistry.EBI
Goethe University
Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σEBI
University of Bari Aldo Moro
Bridged Piperidine Analogues of a High Affinity Naphthalene-Based P2YEBI
National Institute of Diabetes and Digestive and Kidney Diseases
Fluoroalkylation of Dextromethorphan Improves CNS Exposure and Metabolic Stability.EBI
The University of Kansas
Selective AEBI
National Institute of Diabetes and Digestive and Kidney Diseases
Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer's Disease.EBI
Cognition Therapeutics
New tetrahydroisoquinoline-based DEBI
City University of New York
Chemoenzymatic synthesis of 2,6-disubstituted tetrahydropyrans with high σEBI
Westf£Lische Wilhelms-Universit£T M£Nster
Structure-Activity Relationship of Heterocyclic P2YEBI
National Institute of Diabetes and Digestive and Kidney Diseases
Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management.EBI
The State University of New Jersey
Novel σEBI
Westf£Lische Wilhelms-Universit£T M£Nster
Synthesis, binding, and functional properties of tetrahydroisoquinolino-2-alkyl phenones as selective σEBI
Guangdong Medical University
Studies on the affinity of 6-[(EBI
Helmholtz-Zentrum Dresden-Rossendor
Synthesis and SAR Studies of 1EBI
University of Nebraska Medical Center
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases.EBI
Soochow University
Ifenprodil Stereoisomers: Synthesis, Absolute Configuration, and Correlation with Biological Activity.EBI
Westf£Lische Wilhelms-Universit£T M£Nster
Isoquinolinone derivatives as potent CNS multi-receptor DEBI
Jiangsu Ocean University
The Essential Medicinal Chemistry of Cannabidiol (CBD).EBI
University of Minnesota
Negative allosteric modulators of the GluN2B NMDA receptor with phenylethylamine structure embedded in ring-expanded and ring-contracted scaffolds.EBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
Sigma-1 and Sigma-2 Receptor Modulators as Potential Therapeutics for Alzheimer's Disease.EBI
Usona Institute
Fluorinated 2-Arylcyclopropan-1-amines - A new class of sigma receptor ligands.EBI
Universit£T M£Nster
Synthesis and EBI
Wilhelms-Universit�T M�Nster Corrensstr
Virtual Screening for Ligand Discovery at the σEBI
Harvard Medical School
Novel Dithiolane-Based Ligands Combining Sigma and NMDA Receptor Interactions as Potential Neuroprotective Agents.EBI
University of Modena and Reggio Emilia
Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation.EBI
University of Catania
Synthesis, Cytotoxicity Evaluation, and Computational Insights of Novel 1,4-Diazepane-Based Sigma Ligands.EBI
University of Trieste
Isolation and Synthesis of Veranamine, an Antidepressant Lead from the Marine Sponge EBI
University of Mississippi
Thiophene bioisosteres of GluN2B selective NMDA receptor antagonists: Synthesis and pharmacological evaluation of [7]annuleno[b]thiophen-6-amines.EBI
Westf£Lische Wilhelms-Universit£T M£Nster
Benzimidazolone-based selective σEBI
University of Florida
Structure-Based Design of 3-(4-Aryl-1H-1,2,3-triazol-1-yl)-Biphenyl Derivatives as P2Y14 Receptor Antagonists.EBI
National Institute of Diabetes and Digestive and Kidney Diseases
Development of Novel Alkoxyisoxazoles as Sigma-1 Receptor Antagonists with Antinociceptive Efficacy.EBI
East China Normal University
Synthesis of spiro-2,6-dioxopiperazine and spiro-2,6-dioxopyrazine scaffolds using amino acids in a three-component reaction to generate potential Sigma-1 (σEBI
Memorial Sloan Kettering Cancer Center
Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective DEBI
National Institute of Neurological Disorders and Stroke
Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human AEBI
Medical College of Wisconsin
Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and σEBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands.EBI
University of Catania
Discovery of a novel class of potent and selective tetrahydroindazole-based sigma-1 receptor ligands.EBI
Northwestern University
SYA 013 analogs as moderately selective sigma-2 (σEBI
Florida A&M University
Synthesis and Structure-Affinity Relationships of Spirocyclic Benzopyrans with Exocyclic Amino Moiety.EBI
Universit£T M£Nster
Development of Novel Quinoxaline-Based κ-Opioid Receptor Agonists for the Treatment of Neuroinflammation.EBI
Universit£T M£Nster
Design and in Vivo Characterization of AEBI
Medical College of Wisconsin
Modification of the 4-phenylbutyl side chain of potent 3-benzazepine-based GluN2B receptor antagonists.EBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
Impact of hydroxy moieties at the benzo[7]annulene ring system of GluN2B ligands: Design, synthesis and biological evaluation.EBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
3-Amino-chromanes and Tetrahydroquinolines as Selective 5-HTEBI
University of Minnesota Twin Cities
Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents.EBI
University of Trieste
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.EBI
Qbi Covid-19 Research Group (Qcrg)
Pyridine bioisosteres of potent GluN2B subunit containing NMDA receptor antagonists with benzo[7]annulene scaffold.EBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease.EBI
IQM-CSIC
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents.EBI
University of Pavia
New piperidine-based derivatives as sigma receptor ligands. Synthesis and pharmacological evaluation.EBI
University of Trieste
Hydroxymethyl bioisosteres of phenolic GluN2B-selective NMDA receptor antagonists: Design, synthesis and pharmacological evaluation.EBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
Multifunctional thiosemicarbazones and deconstructed analogues as a strategy to study the involvement of metal chelation, Sigma-2 (σEBI
University of Bari Aldo Moro
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.EBI
Csir-National Chemical Laboratory
Synthesis of 3-aza[4.4.3]propellanes with high σEBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms.EBI
Mazandaran University of Medical Sciences
Deconstruction - reconstruction approach to analyze the essential structural elements of tetrahydro-3-benzazepine-based antagonists of GluN2B subunit containing NMDA receptors.EBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
Structure-Guided Modification of Heterocyclic Antagonists of the P2YEBI
National Institute of Diabetes and Digestive and Kidney Diseases
2-Methyltetrahydro-3-benzazepin-1-ols - The missing link in SAR of GluN2B selective NMDA receptor antagonists.EBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
Synthesis, Receptor Affinity, and Antiallodynic Activity of Spirocyclic σ Receptor Ligands with Exocyclic Amino Moiety.EBI
Universit£T M£Nster
Investigating isoindoline, tetrahydroisoquinoline, and tetrahydrobenzazepine scaffolds for their sigma receptor binding properties.EBI
University of Texas At Austin
Synthesis and pharmacological evaluation of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as sigma-2 receptor ligands.EBI
Guangdong Medical University
Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile.EBI
Iqog, Csic
Synthesis and pharmacological evaluation of benzamide derivatives as potent and selective sigma-1 protein ligands.EBI
Universities of Lille
Chiral-pool synthesis of 1,2,4-trisubstituted 1,4-diazepanes as novelσEBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
Do spiroindolines have the potential to replace vesamicol as lead compound for the development of radioligands targeting the vesicular acetylcholine transporter?EBI
Helmholtz-Zentrum Dresden-Rossendorf
Return of DEBI
University of Nebraska Medical Center
Synthesis of conformationally restricted 1,3-dioxanes to analyze the bioactive conformation of 1,3-dioxane-basedσEBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
Lipase-catalyzed kinetic resolution as key step in the synthesis of enantiomerically pureσ ligands with 2-benzopyran structure.EBI
Universit£T M£Nster
Novel Sigma Receptor Ligand-Nitric Oxide Photodonors: Molecular Hybrids for Double-Targeted Antiproliferative Effect.EBI
University of Catania
Reevaluation of fenpropimorph as aσ receptor ligand: Structure-affinity relationship studies at humanσEBI
Virginia Commonwealth University
SPIROCYCLIC MODULATORS OF CHOLESTEROL BIOSYNTHESIS AND THEIR USE FOR PROMOTING REMYELINATIONBDB
Genentech
A CLASS OF FUSED RING COMPOUNDS, AND PREPARATION AND USE THEREOFBDB
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang)
PLASMA KALLIKREIN INHIBITORSBDB
Merck Sharp & Dohme
Acylsulfamide Compound and Pharmaceutical Use ThereforBDB
Japan Tobacco
N-AROMATIC AMIDE COMPOUNDS, PREPARATION METHODS AND USES THEREOFBDB
Shenzhen Edk Pharmaceutical Technology
Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitorsBDB
Incyte
Substituted pyrazolo[1,5-a]pyrimidines as TYK2 inhibitorsBDB
Nimbus Lakshmi
3,4-disubstituted 3-cyclobutene-1,2-diones and use thereofBDB
Allergan
ArylquinazolinesBDB
Merck Patent
 
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19BDB
Pfizer
Selective NR2B antagonistsBDB
Bristol-Myers Squibb
Indole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2BDB
Merck Sharp & Dohme
Benzothiazole compounds and uses thereofBDB
Incyte
Use of physiological cooling active ingredients, and agents containing such active ingredientsBDB
Symrise
Oxazetidine derivatives, process for preparing them and use in human medicine and in cosmeticsBDB
Galderma Research & Development
Optimization of a direct spectrophotometric method to investigate the kinetics and inhibition of sialidases.BDB
Universit�� Degli Studi Di Siena
Highly Potent Cell-Permeable and Impermeable NanoLuc Luciferase Inhibitors.BDB
Promega Biosciences
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseasesBDB
Merck Sharp & Dohme
Inhibition of WDR5 interaction with its binding partnersBDB
The Regents of The University of Michigan
N2,N4-bis(4-(piperazine-1-yl)phenyl)pirimidine-2,4-diamine derivative or pharmaceutically acceptable salt thereof, and composition containing same as active ingredient for preventing or treating cancerBDB
Korea Research Institute of Chemical Technology